Genomic Health (GHDX +5.9%) spikes higher after announcing the national contractor for its Oncotype DX colon cancer testing product has established Medicare coverage for it.
From other sites
at CNBC.com (Apr 25, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs